首頁 › 血液癌症 › 哥倫比亞特區 › Washington
Washington, DC 的 血液癌症 臨床試驗
19 項針對 血液癌症 的研究正在 Washington（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
招募中1 期
- MedStar Georgetown University Hospital, Washington D.C.
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 距離 7 英里
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
招募中1 期
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
招募中觀察性研究
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 距離 7 英里
Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
招募中1/2 期歡迎健康志工
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
招募中3 期
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · 距離 7 英里
Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation
招募中1 期
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
招募中1/2 期歡迎健康志工
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
Longitudinal Studies of Patient With FPDMM
招募中觀察性研究歡迎健康志工
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
招募中1/2 期歡迎健康志工
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
招募中觀察性研究
- The Center for Cancer and Blood Disorders, Bethesda · 距離 7 英里
Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies
招募中1 期
- Childrens National Medical Center, Washington D.C.
Mosaic Trial for Stem Cell Transplant Recipients
招募中
- Georgetown University School of Medicine, Washington D.C.
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中觀察性研究
- Children's National Medical Center, Washington D.C.
- Nih/Niaid, Bethesda · 距離 7 英里
- Nih/Nhlbi, Bethesda · 距離 7 英里
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
招募中1/2 期
- The Center for Cancer and Blood Disorders (CCBD), Bethesda · 距離 7 英里
Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
招募中1/2 期歡迎健康志工
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
招募中觀察性研究
- George Washington University, Washington D.C.
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
招募中觀察性研究歡迎健康志工
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
招募中1 期
- Children's National Medical Center, Washington D.C.
- National Cancer Institute, Pediatric Oncology Branch, Bethesda · 距離 7 英里
其他城市的 血液癌症 試驗
- Houston, TX46 項研究
- New York City, NY26 項研究
- Boston, MA25 項研究
- Seattle, WA18 項研究
- Baltimore, MD18 項研究
- Los Angeles, CA17 項研究
- Durham, NC16 項研究
- Chicago, IL15 項研究
- Philadelphia, PA14 項研究
- Edison, NJ13 項研究
- Nashville, TN13 項研究
- Columbus, OH13 項研究
Washington 的其他研究
- 癌症（所有類型）58 項研究
- 非小細胞肺癌55 項研究
- 乳癌46 項研究
- 轉移性癌症43 項研究
- 肺癌41 項研究
- 前列腺癌38 項研究
- 肥胖症33 項研究
- 大腸直腸癌29 項研究
- 心血管疾病28 項研究
- 膀胱癌26 項研究
- 急性髓系白血病24 項研究
- 卵巢癌23 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。